Global Small Molecule API market - Estimation & Forecast, 2013-2027

 Published On: Aug, 2016 |    No of Pages: 110 |  Published By: Market Research Future | Format: PDF
Request Free Sample
Introduction
The global small molecule API market was valued at $ 132,877.3 million in 2016 and expected to reach $ 279,687.1 million by 2027 at a CAGR of 7 % during the forecast period. The major factors responsible for the growth of global Small molecule API market are growing demand for newly developed small molecules drugs, growing trend of outsourcing and growing pharmaceutical industry in developing nations. The growth barriers are and austerity measures in Europe among others.

The market is majorly categorized on the basis of types which is further segmented into synthetic/chemical API and biological API. On the basis of application the market is segmented into cardiovascular, oncology, diabetes and immunological disorders. On the basis of manufacturing methods the market is segmented into in-house manufacturing and contract manufacturing and geographic regions.

Globally, North America holds the largest market share of global small molecule API market, registering 38.84 % in 2016. 

The scope of global small molecule API market study includes the market value, market size and a detailed analysis of vendor products and strategies.

Key Players
The leading players of the global small molecule API market are Albemarle Corporation, Allergan Plc, Aurobindo Pharma, Cambrex Corporation, Dr. Reddy’s laboratories ltd., Glaxosmithkline Plc, Lonza , Merck Sharp & Dohme Corp., Mylan N.V., Pfizer Inc., Novartis AG, Siegfried AG , Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. and others.

Study Objectives of Small molecule API Market Development and Demand Forecast to 2027 Market
-To provide insights about factors, influencing and affecting the market growth
-To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries
-To provide historically and forecast revenue of the market segments based on type, and sub-segment for global Small molecule API market 
-To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
-To provide economic factors that influence the global Small molecule API market

Target Audience
• Small molecule API companies
• Raw Material Suppliers
• Key executive (CEO and COO) and strategy growth manager

Key Findings
• On the basis of types, synthetic/chemical API accounted for the largest market share of 81.31 % in 2016.
• US accounted for the largest market share of 59.75 % in 2016, with a market value of USD 30,848.3 million and is projected to grow at a CAGR of 6.6 % during the forecast period.

The reports also cover country level analysis:
• North America
• US
• Canada
•  Europe
• Western Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Asia-Pacific
• China
• Japan
• India
• Republic of Korea
• Rest of Asia-Pacific
• Middle East & Africa
TABLE OF CONTENTS
1 INTRODUCTION 12
1.1 DEFINITION 12
1.2 SCOPE OF STUDY 12
1.2.1 RESEARCH OBJECTIVE 12
1.2.2 ASSUMPTIONS & LIMITATIONS 13
1.2.2.1 ASSUMPTIONS 13
1.2.2.2 LIMITATIONS 13
1.3 MARKET STRUCTURE: 13
2 RESEARCH METHODOLOGY 14
2.1 RESEARCH PROCESS: 14
2.2 PRIMARY RESEARCH 15
2.3 SECONDARY RESEARCH: 15
3 MARKET DYNAMICS 16
3.1 DRIVERS 16
3.1.1 GROWING DEMAND FOR NEWLY DEVELOPED SMALL MOLECULES DRUGS 16
3.1.2 GROWING TREND OF OUTSOURCING 16
3.1.3 GROWING PHARMACEUTICAL INDUSTRY IN DEVELOPING NATIONS 17
3.2 RESTRAINTS 17
3.2.1 AUSTERITY MEASURES IN EUROPE 17
3.3 OPPORTUNITIES 17
3.4 MACROECONOMIC INDICATORS 18
4 MARKET FACTOR ANALYSIS 19
4.1 PORTERS FIVE FORCES MODEL 19
4.2 BARGAINING POWER OF SUPPLIERS 20
4.3 BARGAINING POWER OF BUYERS 20
4.4 THREAT OF NEW ENTRANTS 20
4.5 THREAT OF SUBSTITUTES 20
4.6 INTENSITY OF RIVALRY 20
5 GLOBAL SMALL MOLECULES API, BY TYPE 21
5.1 SYNTHETIC/CHEMICAL API 22
5.2 BIOLOGICAL API 23
6 GLOBAL SMALL MOLECULE API MARKET, BY APPLICATION 25
6.1 CARDIOVASCULAR 27
6.2 ONCOLOGY 28
6.3 DIABETES 29
6.4 IMMUNOLOGICAL DISORDERS 30
7 GLOBAL SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 31
7.1 IN-HOUSE MANUFACTURING 33
7.2 CONTRACT MANUFACTURING 34
7.2.1 INTRODUCTION 34
8 GLOBAL SMALL MOLECULE API MARKET, BY REGION 37
8.1 NORTH AMERICA 39
8.1.1 INTRODUCTION 40
8.2 EUROPE 46
8.2.1 INTRODUCTION 47
8.3 ASIA-PACIFIC 58
8.3.1 INTRODUCTION 59
8.4 MIDDLE EAST & AFRICA 72
8.4.1 INTRODUCTION 76
9 COMPETITIVE LANDSCAPE 77
9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS 77
9.1.1 STRATEGIC PARTNERSHIP 78
9.1.2 MERGER & ACQUISITION 78
10 COMPANY PROFILE 80
10.1 ALBEMARLE CORPORATION 80
10.1.1 OVERVIEW 80
10.1.2 PRODUCT OVERVIEW 80
10.1.3 FINANCIALS 81
10.1.4 KEY DEVELOPMENTS 81
10.2 ALLERGAN PLC 82
10.2.1 OVERVIEW 82
10.2.2 PRODUCT OVERVIEW 82
10.2.3 FINANCIALS 83
10.2.4 KEY DEVELOPMENTS 83
10.3 AUROBINDO PHARMA 84
10.3.1 OVERVIEW 84
10.3.2 PRODUCT OVERVIEW 84
10.3.3 FINANCIALS 85
10.3.4 STRATEGY 85
10.3.5 KEY DEVELOPMENT 85
10.4 CAMBREX CORPORATION 86
10.4.1 OVERVIEW 86
10.4.2 PRODUCT OVERVIEW 86
10.4.3 FINANCIALS 87
10.4.4 KEY DEVELOPMENTS 87
10.5 DR. REDDY’S LABORATORIES LTD. 88
10.5.1 OVERVIEW 88
10.5.2 PRODUCT OVERVIEW 88
10.5.3 FINANCIALS 89
10.5.4 KEY DEVELOPMENTS 89
10.6 GLAXOSMITHKLINE PLC 90
10.6.1 OVERVIEW 90
10.6.2 PRODUCT OVERVIEW 90
10.6.3 FINANCIALS 91
10.6.4 STRATEGY 91
10.6.5 KEY DEVELOPMENTS 92
10.7 LONZA 92
10.7.1 OVERVIEW 92
10.7.2 PRODUCT OVERVIEW 92
10.7.3 FINANCIALS 93
10.7.4 STRATEGY 93
10.7.5 KEY DEVELOPMENTS 94
10.8 MERCK SHARP & DOHME CORP. 94
10.8.1 OVERVIEW 94
10.8.2 PRODUCT OVERVIEW 95
10.8.3 FINANCIAL 95
10.8.4 KEY DEVELOPMENTS 96
10.9 MYLAN N.V. 96
10.9.1 OVERVIEW 96
10.9.2 PRODUCT OVERVIEW 97
10.9.3 FINANCIALS 97
10.9.4 KEY DEVELOPMENTS 98
10.10 NOVARTIS AG 98
10.10.1 OVERVIEW 98
10.10.2 PRODUCT OVERVIEW 99
10.10.3 FINANCIALS 99
10.10.4 STRATEGY 99
10.10.5 DEVELOPMENTS 100
10.11 PFIZER INC. 100
10.11.1 OVERVIEW 100
10.11.2 PRODUCT OVERVIEW 101
10.11.3 FINANCIALS 101
10.11.4 KEY DEVELOPMENTS 102
10.12 SIEGFRIED AG 102
10.12.1 OVERVIEW 102
10.12.2 PRODUCT OVERVIEW 102
10.12.3 FINANCIALS 103
10.12.4 KEY DEVELOPMENTS 103
10.13 SUN PHARMACEUTICAL INDUSTRIES LTD. 104
10.13.1 OVERVIEW 104
10.13.2 PRODUCT OVERVIEW 104
10.13.3 FINANCIALS 105
10.13.4 KEY DEVELOPMENTS 105
10.14 TEVA PHARMACEUTICAL INDUSTRIES LTD 106
10.14.1 OVERVIEW 106
10.14.2 PRODUCT OVERVIEW 106
10.14.3 FINANCIALS 107
10.14.4 STRATEGY 107
10.14.5 KEY DEVELOPMENTS 108   

List of Tables
GLOBAL SMALL MOLECULE API MARKET, BY TYPE,  2014-2027 (USD MILLION) 22
TABLE 2  GLOBAL SYNTHETIC/CHEMICAL API MARKET, BY REGION,  2014-2027 (USD MILLION)   23
TABLE 3  GLOBAL BIOLOGICAL API MARKET, BY REGION, 2014-2027  (USD MILLION) 24
TABLE 4  GLOBAL SMALL MOLECULE API MARKET, BY APPLICATION,  2014-2027 (USD MILLION)   26
TABLE 5 GLOBAL SMALL MOLECULE API MARKET: CARDIOVASCULAR, BY REGION, 2014-2027 (USD MILLION) 27
TABLE 6 GLOBAL SMALL MOLECULE API MARKET: ONCOLOGY,  BY REGION, 2014-2027 (USD MILLION) 28
TABLE 7 GLOBAL SMALL MOLECULE API MARKET: DIABETES,  BY REGION, 2014-2027 (USD MILLION) 29
TABLE 8 GLOBAL SMALL MOLECULE API MARKET: IMMUNOLOGICAL DISORDERS, BY REGION, 2014-2027 (USD MILLION) 30
TABLE 9 GLOBAL SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 32
TABLE 10 GLOBAL SMALL MOLECULE API MARKET, BY IN-HOUSE MANUFACTURING, 2014-2027 (USD MILLION) 33
TABLE 11 GLOBAL SMALL MOLECULE API MARKET, BY CONTRACT MANUFACTURING, 2014-2027 (USD MILLION) 34
TABLE 12 GLOBAL SMALL MOLECULE API MARKET, BY REGION,  2014-2027 (USD MILLION) 38
TABLE 13 NORTH AMERICA SMALL MOLECULE API MARKET,  BY COUNTRY, 2014-2027 (USD MILLION) 39
TABLE 14 NORTH AMERICA SMALL MOLECULE API MARKET, BY TYPE,  2014-2027 (USD MILLION)   40
TABLE 15 NORTH AMERICA SMALL MOLECULE API MARKET,  BY APPLICATION, 2014-2027 (USD MILLION) 41
TABLE 16 NORTH AMERICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2014-2027 (USD MILLION) 42
TABLE 17 U.S. SMALL MOLECULE API MARKET, BY TYPE, 2014-2027  (USD MILLION) 43
TABLE 18 U.S. SMALL MOLECULE API MARKET, BY APPLICATION,  2014-2027 (USD MILLION)   44
TABLE 19 U.S. SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 44
TABLE 20 CANADA SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 45
TABLE 21 CANADA SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION)   45
TABLE 22 CANADA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 46
TABLE 23 EUROPE SMALL MOLECULE API MARKET, BY COUNTRY,  2014-2027 (USD MILLION)   47
TABLE 24 EUROPE SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 48
TABLE 25 EUROPE SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION)   49
TABLE 26 EUROPE SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2014-2027 (USD MILLION) 50
TABLE 27 GERMANY SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 51
TABLE 28 GERMANY SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION)   51
TABLE 29 GERMANY SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2014-2027 (USD MILLION) 52
TABLE 30 FRANCE SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 52
TABLE 31 FRANCE SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION)   53
TABLE 32 FRANCE SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2014-2027 (USD MILLION) 53
TABLE 33 U.K. SMALL MOLECULE API MARKET, BY TYPE, 2014-2027  (USD MILLION) 54
TABLE 34 U.K.  SMALL MOLECULE API MARKET, BY APPLICATION,  2014-2027 (USD MILLION)   54
TABLE 35 U.K.  SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2014-2027 (USD MILLION) 55
TABLE 36 ITALY SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 55
TABLE 37 ITALY SMALL MOLECULE API MARKET, BY APPLICATION,  2014-2027 (USD MILLION)   56
TABLE 38 ITALY SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2014-2027 (USD MILLION) 56
TABLE 39 SPAIN SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 57
TABLE 40 SPAIN SMALL MOLECULE API MARKET, BY APPLICATION,  2014-2027 (USD MILLION)   57
TABLE 41 SPAIN SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2014-2027 (USD MILLION) 58
TABLE 42 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY COUNTRY, 2014-2027 (USD MILLION)   59
TABLE 43 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY TYPE,  2014-2027 (USD MILLION)   60
TABLE 44 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 61
TABLE 45 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 62
TABLE 46 JAPAN SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 63
TABLE 47 JAPAN SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION)   63
TABLE 48 JAPAN SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 64
TABLE 49 CHINA SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 64
TABLE 50 CHINA SMALL MOLECULE API MARKET, BY APPLICATION,  2014-2027 (USD MILLION)   65
TABLE 51 CHINA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 65
TABLE 52 INDIA SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 66
TABLE 53 INDIA SMALL MOLECULE API MARKET, BY APPLICATION,  2014-2027 (USD MILLION)   66
TABLE 54 INDIA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 67
TABLE 55 REPUBLIC OF KOREA SMALL MOLECULE API MARKET, BY TYPE, 2014-2027 (USD MILLION) 68
TABLE 56 REPUBLIC OF KOREA SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION) 68
TABLE 57 REPUBLIC OF KOREA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 69
TABLE 58 AUSTRALIA SMALL MOLECULE API MARKET, BY TYPE,  2014-2027 (USD MILLION) 70
TABLE 59 AUSTRALIA SMALL MOLECULE API MARKET, BY APPLICATION, 2014-2027 (USD MILLION)   70
TABLE 60 AUSTRALIA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 71
TABLE 61 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET,  BY REGION, 2014-2027 (USD MILLION) 72
TABLE 62 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET,  BY TYPE, 2014-2027 (USD MILLION) 73
TABLE 63 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET,  BY APPLICATION, 2014-2027 (USD MILLION) 74
TABLE 64 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET,  BY MANUFACTURING METHODS, 2014-2027 (USD MILLION) 75   

List of Figures
RESEARCH PROCESS 14
FIGURE 2 PORTERS FIVE FORCES MODEL 19
FIGURE 3 GLOBAL SMALL MOLECULE API MARKET, BY TYPE 22
FIGURE 4 GLOBAL SMALL MOLECULE API MARKET, BY APPLICATION 26
FIGURE 5 GLOBAL SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 32
FIGURE 6 CONTRACT MANUFACTURING ORGANIZATIONS: MARKET SHARE ANALYSIS (%) 35
FIGURE 7 GLOBAL SMALL MOLECULE API MARKET, BY REGION 38
FIGURE 8 NORTH AMERICA SMALL MOLECULE API MARKET,  BY COUNTRY (%) 39
FIGURE 9 NORTH AMERICA SMALL MOLECULE API MARKET, BY TYPE 40
FIGURE 10 NORTH AMERICA SMALL MOLECULE API MARKET, BY APPLICATION 41
FIGURE 11 NORTH AMERICA SMALL MOLECULE API MARKET,  BY MANUFACTURING METHOD   42
FIGURE 12 EUROPE SMALL MOLECULE API MARKET, BY COUNTRY (%) 46
FIGURE 13 EUROPE SMALL MOLECULE API MARKET, BY TYPE 48
FIGURE 14 EUROPE SMALL MOLECULE API MARKET, BY APPLICATION 49
FIGURE 15 EUROPE SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD 50
FIGURE 16 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY COUNTRY (%) 58
FIGURE 17 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY TYPE 60
FIGURE 18 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY APPLICATION 61
FIGURE 19 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 62
FIGURE 20 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET,  BY COUNTRY (%) 72
FIGURE 21 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET,  BY TYPE 73
FIGURE 22 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET,  BY APPLICATION 74
FIGURE 23 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET,  BY MANUFACTURING METHODS 75
FIGURE 24 GLOBAL SMALL MOLECULE API MARKET: COMPANY SHARE ANALYSIS, 2015 (%) 77

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.